|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 604.80 INR | +4.12% |
|
-4.85% | -19.52% |
| 10/02 | Supriya Lifescience Limited, Q3 2026 Earnings Call, Feb 10, 2026 | |
| 10/02 | Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| Capitalization | 4.87TCr 53Cr 46Cr 41Cr 39Cr 72Cr 74Cr 484.49Cr 194.01Cr 2.33TCr 198.9Cr 194.68Cr 8.36TCr | P/E ratio 2026 * |
24.3x | P/E ratio 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise value | 4.87TCr 53Cr 46Cr 41Cr 39Cr 72Cr 74Cr 484.49Cr 194.01Cr 2.33TCr 198.9Cr 194.68Cr 8.36TCr | EV / Sales 2026 * |
5.79x | EV / Sales 2027 * | 4.79x |
| Free-Float |
27.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supriya Lifescience Limited
| 1 day | +4.12% | ||
| 1 week | -4.85% | ||
| Current month | -7.66% | ||
| 1 month | -11.96% | ||
| 3 months | -17.55% | ||
| 6 months | -7.60% | ||
| Current year | -19.52% |
| 1 week | 573.4 |  | 638.2 |
| 1 month | 573.4 | | 720.8 |
| Current year | 573.4 | | 775 |
| 1 year | 573.4 | | 842 |
| 3 years | 170.15 | | 842 |
| 5 years | 170.15 | | 842 |
| 10 years | 170.15 | | 842 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 34 | 01/08/2024 | |
| Chief Executive Officer | 35 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 25/03/2021 | |
| Director/Board Member | 73 | 24/01/2025 | |
| Director/Board Member | 67 | 25/03/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.12% | -4.85% | -2.78% | +189.66% | 51Cr | |
| -0.70% | -0.63% | +20.68% | +217.87% | 90TCr | |
| +0.46% | -1.23% | +45.32% | +60.75% | 58TCr | |
| -0.19% | -2.93% | +4.78% | +51.63% | 40TCr | |
| +0.84% | -5.68% | +9.04% | +27.14% | 34TCr | |
| -2.63% | -3.48% | +20.34% | +63.50% | 31TCr | |
| +1.47% | -1.86% | +23.75% | +36.98% | 30TCr | |
| -0.02% | -2.29% | +22.95% | +8.73% | 29TCr | |
| -0.41% | -0.42% | +14.68% | +64.76% | 20TCr | |
| +1.32% | +0.49% | +26.75% | +86.87% | 18TCr | |
| Average | +0.43% | -2.05% | +18.55% | +80.79% | 35.11TCr | |
| Weighted average by Cap. | -0.10% | -1.91% | +22.22% | +92.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 840Cr 9.15Cr 7.85Cr 7.1Cr 6.8Cr 12Cr 13Cr 84Cr 33Cr 402.72Cr 34Cr 34Cr 1.44TCr | 1.02TCr 11Cr 9.5Cr 8.58Cr 8.22Cr 15Cr 15Cr 101.1Cr 40Cr 486.95Cr 42Cr 41Cr 1.74TCr |
| Net income | 200.1Cr 2.18Cr 1.87Cr 1.69Cr 1.62Cr 2.96Cr 3.05Cr 20Cr 7.98Cr 96Cr 8.18Cr 8Cr 343.48Cr | 246.4Cr 2.68Cr 2.3Cr 2.08Cr 1.99Cr 3.64Cr 3.76Cr 25Cr 9.82Cr 118.13Cr 10Cr 9.85Cr 422.96Cr |
| Net Debt | - | - |
Employees
515
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | 604.80 ₹ | +4.12% | 1,05,837 |
| 09/26/09 | 580.85 ₹ | -7.49% | 4,78,803 |
| 06/26/06 | 627.90 ₹ | +0.58% | 59,548 |
| 05/26/05 | 624.25 ₹ | +0.64% | 72,704 |
| 04/26/04 | 620.30 ₹ | -2.41% | 93,123 |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition